What you need to know about bird flu. Public health experts are closely watching avian influenza, which has affected chickens ...

Zoetis (ZTS) announced that the U.S. Department of Agriculture, Center for Veterinary Biologics, has issued the company a conditional license ...

commonly known as avian influenza. With growing concerns over the virus’s potential impact on public health, ICMR has begun the process of developing a vaccine for human use. The organization is ...

There have been 67 confirmed human bird flu cases in the U.S. since April 2024. Moderna has been awarded approximately $590 million from the federal government to help speed up the development of ...

Scientists have uncovered a blood-based molecular signature that can predict vaccine durability. Could this change ...

manufacturers for joint collaboration in research and development for development of human vaccine candidate against H5N1. The avian influenza H5N1, a highly pathogenic strain of bird flu ...

Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, ...

AIM ImmunoTech Inc. announced plans to advance its drug Ampligen as a vaccine adjuvant for avian ... A against highly pathogenic avian influenza virus strains H5N1, H7N9 and H7N3.

The Indian Council of Medical Research (ICMR) has begun the process of development of a vaccine against the deadly and highly-pathogenic H5N1 virus, also called avian influenza. ICMR will develop ...

This virus was named Influenza B and the inactivated influenza vaccine had to be bivalent to provide protection against both types of influenza viruses (Figure 1). Thus, in 1942, 10,000 doses of ...

Inc. (NYSE American: AIM) has announced its intention to develop Ampligen as a vaccine adjuvant for avian influenza. This ...